Notice Number: NOT-HL-18-582
Key Dates
Release Date: February 07, 2018
RFA-HL-17-015
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform potential applicants of a clarification to Key Dates for RFA-HL-17-015 "Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)". AIDS applications in response to this FOA are due on May 7, 2018 and September 7, 2018 as indicated below.
Part 1. Key Dates
Currently reads:
AIDS Application Due Date(s) |
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Modified to read:
AIDS Application Due Date(s) |
May 7, 2018 and September 7, 2018, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Martha S. Lundberg, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0513
Email: lundberm@nhlbi.nih.gov
and Human Services (HHS)
